The pooled estimate from the studies suggested that the addition of testosterone to HT regimens improved sexual function scores for postmenopausal women .
A significant adverse effect was a decrease in high-density lipoprotein ( HDL ) cholesterol levels .
However , there is evidence that adding testosterone to HT has a beneficial effect on sexual function in postmenopausal women .
There was a reduction in HDL cholesterol associated with the addition of testosterone to the HT regimens .
It is , therefore , difficult to estimate the effect of testosterone on sexual function in association with any individual hormone treatment regimen
BACKGROUND : The value of adding testosterone to hormone therapy ( HT ) for the management of peri- and postmenopausal women is controversial and has not been systematic ally review ed .
OBJECTIVES : To determine the benefits and risks of testosterone therapy for peri- and postmenopausal women taking hormone therapy .
Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women.
PURPOSE To determine whether systemic replacement with combined esterified estrogen ( EE ) and methyltestosterone ( MT ) ( EE + MT ) would reduce symptoms and promote clinical improvement in postmenopausal women with dry eye syndrome ( DES ) . DESIGN Retrospective , noncomparative , interventional case series . METHODS Investigators review ed the charts of 11 postmenopausal women treated within the last 3 years with EE + MT .  RESULTS The mean patient age was 65.2 years ( st and ard deviation [ SD ] 11.4 , range 48 - 84 years ) . The mean treatment duration was 12.2 months ( SD 6.2 months , range 4 - 24 months ) . Ten ( 91 % ) of 11 patients reported improvement in dry eye symptoms while receiving treatment . For these 10 , relief occurred after an average of 4.1 months of treatment ( SD 3.2 , range , 1 - 9 months ) . CONCLUSIONS Treatment with EE + MT may be efficacious for DES of various etiologies . A r and omized placebo-controlled trial is planned to further evaluate these encouraging findings
The pooled estimate from the studies suggested that the addition of testosterone to HT regimens improved sexual function scores for postmenopausal women .
A significant adverse effect was a decrease in high-density lipoprotein ( HDL ) cholesterol levels .
However , there is evidence that adding testosterone to HT has a beneficial effect on sexual function in postmenopausal women .
There was a reduction in HDL cholesterol associated with the addition of testosterone to the HT regimens .
It is , therefore , difficult to estimate the effect of testosterone on sexual function in association with any individual hormone treatment regimen
BACKGROUND : The value of adding testosterone to hormone therapy ( HT ) for the management of peri- and postmenopausal women is controversial and has not been systematic ally review ed .
OBJECTIVES : To determine the benefits and risks of testosterone therapy for peri- and postmenopausal women taking hormone therapy .